| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
-71,818 | -63,188 | 0 | 0 | 0 | ||
Adjustments to reconcile net loss to net cash used in operating activities | ||||||
Depreciation | ||||||
339 | 265 | 0 | 0 | 0 | ||
Stock-based compensation | ||||||
5,331 | 4,311 | 0 | 0 | 0 | ||
Changes in operating assets and liabilities | ||||||
Prepaid expenses and other current assets | ||||||
526 | 5,847 | 0 | 0 | 0 | ||
Other long-term assets | ||||||
0 | - | - | - | - | ||
Operating lease right-of-use asset | ||||||
1,639 | 1,637 | 0 | 0 | 0 | ||
Accounts payable | ||||||
1,990 | 3,921 | 0 | 0 | 0 | ||
Accrued expenses and other current liabilities | ||||||
4,043 | 3,853 | 0 | 0 | 0 | ||
Operating lease liabilities | ||||||
-856 | -706 | 0 | 0 | 0 | ||
Net cash used in operating activities | ||||||
-61,675 | -55,754 | 0 | 0 | 0 | ||
Cash flows from investing activities | ||||||
Purchases of property and equipment | ||||||
2,167 | 2,136 | 0 | 0 | 0 | ||
Net cash used in investing activities | ||||||
-2,167 | -2,136 | 0 | 0 | 0 | ||
Cash flows from financing activities | ||||||
Payment of issuance costs for preferred stock | ||||||
- | 166 | 0 | 0 | 0 | ||
Proceeds from exercise of stock options | ||||||
0 | - | - | - | - | ||
Net cash provided by financing activities | ||||||
113,155 | 162,927 | 0 | 0 | 0 | ||
Net increase (decrease) in cash, cash equivalents and restricted cash | ||||||
0 | - | - | - | 0 | ||
Series B Preferred Stock | ||||||
Proceeds from issuance of Series B Preferred Stock | ||||||
- | 50,000 | 0 | 0 | 0 | ||